Contained pilot granulation system
GEA Pharma Systems ? Aeromatic-Fielder? has launched a complete production plant that takes the process from dispensed raw materials to finished tablet.
GEA Pharma Systems – Aeromatic-Fielder™ has launched a complete production plant that takes the process from dispensed raw materials to finished tablet. The system clearly demonstrates the flexibility that can be achieved throughout the process – including high shear granulation, pelletization and blending, etc. – in a totally contained environment. It illustrates how GEA Pharma Systems’ inspired technology can be selected to form a total solution tailored to suit each user’s specific requirements, whether through integration or split valve technology.
The system is aimed at producers of small quantities of highly potent compounds. The intelligent contained handling systems inherent in the GEA Pharma pilot plant allow it to be flexible, efficient, clean and safe without the need for expensive, bulky and difficult to clean isolator systems. Furthermore the level of containment avoids the need for costly and uncomfortable airsuits, allowing the users to focus on the product, creating faster and more secure results.
At the heart of the production plant are PharmaConnect®, and Flexstream™. PharmaConnect® is GEA’s innovative, modular granulation and blending system offering an unbeatable range of process types and capacities; FlexStream™ is the world leading process technology for spray granulation and pellet coating, delivering unbeatable benefits in terms of greater productivity, lower running costs and a robust and scaleable process.
For further business information contact:Mark Rowland - Product Manager
GEA Pharma Systems Ltd - Aeromatic-Fielder™
Phone: +44 2380 242232
Email: mark.rowland@geagroup.comhttp://www.gea-ps.com/
Profile:GEA Pharma Systems supplies process equipment for the manufacturing of oral and parenteral dosage forms. Brands: Aeromatic-Fielder™ and Collette™ - batch and continuous granulation, drying, pelletizing and coating; Buck® - contained materials handling; Courtoy™ - tablet compression; Lyophil™ - pharmaceutical freeze drying and Diessel™ - fermentation and liquid formulation.
Market Demands and Emerging Technologies Shape Outsourcing Models
June 5th 2025Trends in certain forms of drug delivery, as well as the emergence of artificial intelligence, are playing roles in evolving the nature of partnerships, but there are new types of partnerships gaining steam as well.
Drug Solutions Podcast: Novel Drug Delivery Approaches: Refining AAV Vector Deliveries
May 30th 2025In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) vectors, as viewed by two industry experts who recently exhibited at the annual ASGCT meeting.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
The Role of On-Demand Manufacturing and Derisking in Accelerating Early Clinical Trial Success
June 4th 2025Small pharmaceutical companies are constantly seeking innovative solutions to streamline early clinical trials. Adaptive clinical trials offer important benefits to sponsors and patients, both from a commercial and ethical standpoint. These trials offer flexibility and efficiency, especially in the early stages, where trial protocols can be adjusted based on interim data, such as introducing new doses or modifying participant sample size. However, adjusting manufacturing demand during an adaptive trial can be complicated, and strict regulatory requirements present significant challenges. On-demand manufacturing provides a robust solution, allowing for real-time supply and demand adjustments and improved trial flexibility. This paper explores how on-demand manufacturing meets the operational needs of adaptive trials and aligns with regulatory expectations.
